222 related articles for article (PubMed ID: 31818285)
1. Serum bilirubin level is associated with exercise capacity and quality of life in chronic obstructive pulmonary disease.
Leem AY; Kim YS; Lee JH; Kim TH; Kim HY; Oh YM; Lee SD; Jung JY
Respir Res; 2019 Dec; 20(1):279. PubMed ID: 31818285
[TBL] [Abstract][Full Text] [Related]
2. Low serum lymphocyte level is associated with poor exercise capacity and quality of life in chronic obstructive pulmonary disease.
Moon SW; Leem AY; Kim YS; Lee JH; Kim TH; Oh YM; Shin H; Chang J; Jung JY;
Sci Rep; 2020 Jul; 10(1):11700. PubMed ID: 32678181
[TBL] [Abstract][Full Text] [Related]
3. Relationship of vitamin D status with lung function and exercise capacity in COPD.
Jung JY; Kim YS; Kim SK; Kim HY; Oh YM; Lee SM; Seo JB; Lee SD;
Respirology; 2015 Jul; 20(5):782-9. PubMed ID: 25868752
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease.
Shin TR; Oh YM; Park JH; Lee KS; Oh S; Kang DR; Sheen S; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Rhee CK; Choe KH; Lee JS; Lee SD
J Korean Med Sci; 2015 Oct; 30(10):1459-65. PubMed ID: 26425043
[TBL] [Abstract][Full Text] [Related]
5. Correlations Between Serum Decoy Receptor 3 and Airflow Limitation and Quality of Life in Male Patients with Stable Stage and Acute Exacerbation of COPD.
Ghobadi H; Hosseini N; Aslani MR
Lung; 2020 Jun; 198(3):515-523. PubMed ID: 32211977
[TBL] [Abstract][Full Text] [Related]
6. Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group.
Durheim MT; Smith PJ; Babyak MA; Mabe SK; Martinu T; Welty-Wolf KE; Emery CF; Palmer SM; Blumenthal JA
Ann Am Thorac Soc; 2015 Mar; 12(3):349-56. PubMed ID: 25568929
[TBL] [Abstract][Full Text] [Related]
7. Correlation of serum fatty acid binding protein-4 and interleukin-6 with airflow limitation and quality of life in stable and acute exacerbation of COPD.
Aslani MR; Ghazaei Z; Ghobadi H
Turk J Med Sci; 2020 Apr; 50(2):337-345. PubMed ID: 31905499
[TBL] [Abstract][Full Text] [Related]
8. Impact of symptom variability on clinical outcomes in COPD: analysis of a longitudinal cohort.
Kim MA; Suh MK; Park J; Kim JH; Kim TH; Kim EK; Oh YM; Lee SD; Lee JH
Int J Chron Obstruct Pulmon Dis; 2019; 14():2135-2144. PubMed ID: 31571850
[TBL] [Abstract][Full Text] [Related]
9. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
[TBL] [Abstract][Full Text] [Related]
10. Impact Of Peak Oxygen Pulse On Patients With Chronic Obstructive Pulmonary Disease.
Wu CW; Hsieh PC; Yang MC; Tzeng IS; Wu YK; Lan CC
Int J Chron Obstruct Pulmon Dis; 2019; 14():2543-2551. PubMed ID: 31819392
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
Lee JY; Chon GR; Rhee CK; Kim DK; Yoon HK; Lee JH; Yoo KH; Lee SH; Lee SY; Kim TE; Kim TH; Park YB; Hwang YI; Kim YS; Jung KS
J Korean Med Sci; 2016 Apr; 31(4):553-60. PubMed ID: 27051239
[TBL] [Abstract][Full Text] [Related]
12. Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities.
Perez T; Deslée G; Burgel PR; Caillaud D; Le Rouzic O; Zysman M; Escamilla R; Jebrak G; Chanez P; Court-Fortune I; Brinchault-Rabin G; Nesme-Meyer P; Paillasseur JL; Roche N;
Int J Chron Obstruct Pulmon Dis; 2019; 14():1399-1410. PubMed ID: 31308646
[No Abstract] [Full Text] [Related]
13. The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease.
Zhang M; Tang J; Yin J; Wang X; Feng X; Yang X; Shan H; Zhang Q; Zhang J; Li Y
Int J Chron Obstruct Pulmon Dis; 2018; 13():357-363. PubMed ID: 29403273
[TBL] [Abstract][Full Text] [Related]
14. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
15. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
16. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
17. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
[TBL] [Abstract][Full Text] [Related]
18. Effects of a simple prototype respiratory muscle trainer on respiratory muscle strength, quality of life and dyspnea, and oxidative stress in COPD patients: a preliminary study.
Leelarungrayub J; Pinkaew D; Puntumetakul R; Klaphajone J
Int J Chron Obstruct Pulmon Dis; 2017; 12():1415-1425. PubMed ID: 28553094
[TBL] [Abstract][Full Text] [Related]
19. Relationship between serum cardiac troponin T level and cardiopulmonary function in stable chronic obstructive pulmonary disease.
Hattori K; Ishii T; Motegi T; Kusunoki Y; Gemma A; Kida K
Int J Chron Obstruct Pulmon Dis; 2015; 10():309-20. PubMed ID: 25709425
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the GOLD combined COPD assessment staging system and bacterial isolation.
Aydemir Y; Aydemir Ö; Kalem F
Int J Chron Obstruct Pulmon Dis; 2014; 9():1045-51. PubMed ID: 25298733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
